SARAH SHAHEEN: Open Payments
NPI 1235763228 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 62 payments from 19 companies in 2025. Trend: 2023 $304 · 2024 $743 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $436 |
| ABBVIE INC. | 19 | $276 |
| Janssen Biotech, Inc. | 6 | $174 |
| Ardelyx, Inc. | 3 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| GENZYME CORPORATION | 2 | $48 |
| Organon LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| RedHill Biopharma Inc. | 1 | $30 |
Products named: REZDIFFRA, TREMFYA, LINZESS, IBSRELA, CREON, XIFAXAN, DUPIXENT, HADLIMA.
Industry payments across CA — which companies pay providers there.
